Tianyu Biological Controller Faces SEC Sanctions for Illegal Stock Sales
Luo Weiguo, the actual controller of Tianyu Biological, has received a prior notification of administrative penalties from the China Securities Regulatory Commission (CSRC) Chongqing Bureau. The CSRC alleges that Luo Weiguo concealed his concerted action relationship by fabricating fund share transfer transactions to evade restrictions on share reduction ratios. Between November and December 2021, he allegedly engaged in illegal share reductions of Tianyu Biological stock, selling 11,677,738 shares. The total value of these illegal sales amounted to 165 million yuan, with illicit gains of 15.8533 million yuan. The CSRC proposes to issue a warning to Luo Weiguo, confiscate his illegal gains of 15.8533 million yuan, and impose a fine of 19.75 million yuan. The company has stated that this matter is personal to Luo Weiguo and is unrelated to the listed company, asserting that it will not have a significant impact on the company's production and operations.
This event highlights regulatory scrutiny over stock trading practices designed to circumvent ownership disclosure and trading limits. The CSRC's proposed penalties aim to deter similar actions by imposing financial sanctions equivalent to the illegal gains plus a substantial fine. While the company asserts no impact on operations, such actions by a principal controller can erode investor confidence and signal potential governance weaknesses. Future market participants will likely face increased oversight on complex transaction structures intended to obscure beneficial ownership or trading intentions, particularly in the context of evolving disclosure requirements and the increasing sophistication of financial market surveillance.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.